Audrey M. Hamilton

Hematology
136 Mountainview Blvd
Basking Ridge, NJ 07920

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.

Journal: Blood advances
Published: July 17, 2024

Consolidation trends in vascular surgery.

Consolidation trends in vascular surgery.

Journal: Journal of vascular surgery
Published: July 11, 2023

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.

Journal: Blood advances
Published: February 07, 2023

From Debt to Dollars: Assessing a General Surgeon's Career Value.

From Debt to Dollars: Assessing a General Surgeon's Career Value.

Journal: The Journal of surgical research
Published: January 09, 2023

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.

Journal: Cancer cell
Published: May 22, 2022

Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.

Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.

Journal: Leukemia & lymphoma
Published: November 17, 2021

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.

Journal: Blood cancer journal
Published: September 15, 2021

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial.

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Haematology
Published: August 25, 2021

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 25, 2021

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 14, 2021

Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.

Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 28, 2021

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse.

Journal: Blood cancer journal
Published: January 07, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026